Antigenic Variant Of Highly Pathogenic Avian Influenza A(H7N9) Virus, China, 2019.
by: Jiang W, Hou G, Li J, Peng C, Wang S, Liu S, Zhuang Q, Yuan L, Yu X, Li Y, Wang J, Liu H. in Emerg Infect Dis

Non-Leishmania Parasite In Fatal Visceral Leishmaniasis-like Disease, Brazil.
by: Domagalska MA, Dujardin JC. in Emerg Infect Dis

Exposure To Ebola Virus And Risk For Infection With Malaria Parasites, Rural Gabon.
by: Abbate JL, Becquart P, Leroy E, Ezenwa VO, Roche B. in Emerg Infect Dis

Hepatitis A Virus Genotype IB Outbreak Among Internally Displaced Persons, Syria.
by: Kaddoura M, Allaham R, Abubakar A, Ezzeddine A, Barakat A, Mala P, Zaraket H. in Emerg Infect Dis

Ocular Spiroplasma Ixodetis In Newborns, France.
by: Matet A, Le Flèche-Matéos A, Doz F, Dureau P, Cassoux N. in Emerg Infect Dis

Musculoskeletal Pain In 6-year-old Children: The Generation R Study.
by: van den Heuvel MM, Jansen PW, Bindels PJE, Bierma-Zeinstra SMA, van Middelkoop M. in Pain

Emergency Department Management Of Eating Disorder Complications In Pediatric Patients
by: Ernest S, Kuntz HM. in Pediatr Emerg Med Pract

T-495, A Novel Low Cooperative M1 Receptor Positive Allosteric Modulator, Improves Memory Deficits Associated With Cholinergic Dysfunction And Is Characterized By Low Gastrointestinal Side Effect Risk.
by: Mandai T, Sako Y, Kurimoto E, Shimizu Y, Nakamura M, Fushimi M, Maeda R, Miyamoto M, Kimura H. in Pharmacol Res Perspect

Sultiame Pharmacokinetic Profile In Plasma And Erythrocytes After Single Oral Doses: A Pilot Study In Healthy Volunteers.
by: Dao K, Thoueille P, Decosterd LA, Mercier T, Guidi M, Bardinet C, Lebon S, Choong E, Castang A, Guittet C, Granier LA, Buclin T. in Pharmacol Res Perspect

Editorial: HBV-the Promise Of A New Era In Therapeutics.
by: Price JC, Bhattacharya D. in Aliment Pharmacol Ther

Corrigendum.
by: in Aliment Pharmacol Ther

Letter: Clinical Outcomes Of Patients With Hepatitis D Infection In The Liver Transplant Setting.
by: Ferrarese A, Sciarrone S, Gambato M, Germani G, Senzolo M, Boccagni P, Cillo U, Burra P, Russo FP. in Aliment Pharmacol Ther

Letter: Clinical Outcomes Of Patients With Hepatitis D Infection In The Liver Transplant Setting-authors' Reply.
by: Brancaccio G, Gaeta GB. in Aliment Pharmacol Ther

Letter: The Gap Between Guidelines And Real Clinical Practice For Dysplasia Surveillance In Inflammatory Bowel Disease.
by: Mocciaro F, Scimeca D, Conte E, Bonaccorso A, Magro B, Lo Mastro M, Di Mitri R. in Aliment Pharmacol Ther

Addressing The Perceived Duality Of Represented And Unrepresented Patients: Legal Findings In A Moral Context.
by: Sperry BP, DeMartino ES, Mueller PS. in Am J Bioeth

Upstream Influences And Fair Subject Selection.
by: Jecker NS. in Am J Bioeth

Bolstering Surrogate Decision Making For Marginally Represented And Unrepresented Patients: One System's Approach And Experience.
by: Lesandrini J, Potter J. in Am J Bioeth

Fair Subject Selection Procedures Must Consider Scientific Uncertainty And Variability In Risk And Benefit Perception.
by: Smith E, Dupras C. in Am J Bioeth

Risk Limits In Fair Subject Selection.
by: Steel R. in Am J Bioeth

Can The Principles Of Research Ethics Help Us Distribute Clinical Resources More Fairly?
by: Giunta H, Sharp RR. in Am J Bioeth

From Solo Decision Maker To Multi-Stakeholder Process: A Defense And Recommendations.
by: Ozar D, Vukov J, Rempala K, Meda R. in Am J Bioeth

Compassionate Care For The Unconscious And Incapacitated.
by: Young MJ. in Am J Bioeth

Context Is Needed When Assessing Fair Subject Selection.
by: Schaefer GO. in Am J Bioeth

Four Faces Of Fair Subject Selection.
by: MacKay D, Saylor KW. in Am J Bioeth

Moral Intimacy, Authority, And Discretion.
by: Moore B, Nelson RH. in Am J Bioeth